White papers - all assets – Page 227
-
White papers
Investment View - The New Age of Financial Repression
Given the surge in government and corporate debt, policy will inevitably focus on making this load sustainable: financial repression, spearheaded by central banks, is set to reach a whole new level.
-
White papers
Uneven Climb Through Recovery
Our CIOs’ Global Investment Outlook offers perspective on the investment landscape and the US elections.
-
White papers
The case for EM single country allocation post-pandemic
As businesses adjust to the new “normal,” we believe the case for international markets is, once again, strong.
-
White papers
HEINEKEN case study - UK Institutional
HEINEKEN has improved the standard and transparency of its business conduct policies, increasing investor confidence.
-
White papers
Green bonds alone won’t get us to Paris: we need firm-level action
A new paper by the Bank of International Settlements (BIS) argues that if we are to accelerate the decarbonisation of the economy, the focus needs to move from behaviour at the green-project level to that of individual companies.
-
White papers
Flexibility and Fundamentals
The new environment of zero rates and higher credit market volatility calls for a new approach to durable income investing—one that can go anywhere, but remains anchored in bottom-up conviction.
-
White papers
Small Emerging Market Companies Driving Big Innovations
Amid seismic disruptions from COVID-19, global equity markets remain enamored with technology giants.
-
White papers
Positioning for a green recovery from COVID-19
The improving economics of renewable power generation and the rise of electric vehicles and green hydrogen mean it is increasingly possible to decouple economic growth and carbon emissions. We believe Asia should follow the EU’s plan for EUR 225 billion in (truly) green bonds.
-
White papers
Evaluating the Options
Volatility is not a word that the Options market is a stranger to, but after a period of relative calm, Options market volatility has returned for the foreseeable future. The first question that comes to mind is–are the opportunities still there amid these volatile times? And if so, are emerging Options investors in a good position to go out and find them?
-
White papers
Politics, economics and a pandemic: Equity markets under pressure
September saw profit-taking on equities amid investor concerns over COVID-19 as well as economic and political uncertainties. After rallying for five months, global equities fell. Further fiscal support measures are taking shape, but only slowly, leaving central banks to lobby for more haste.
-
White papers
President Trump’s positive COVID-19 test shakes up election, markets
President Trump announced in a tweet shortly before 1:00 a.m. on Friday October 2nd that he and the First Lady of the United States (FLOTUS) tested positive for COVID-19. We look at the potential repercussions from this dramatic news in this Q&A.
-
White papers
Disruptive technology in the COVID-19 era
Within the global economy, COVID-19 has acted as a formidable accelerator of trends driving disruptive technology. Valuations of information technology stocks have soared, raising questions about the extent of the rally. Guy Davies, chief investment officer for fundamental active equities, explains why this time may be different.
-
White papers
You asked, we answer
Our Global Views team attempts to answer some of the questions often asked by our clients.
-
White papers
Is France still on track to reduce its competitiveness gap vs. Germany?
Germany clearly outperformed France on most macroeconomic metrics in the last two decades. Yet France has implemented many supply-side reforms since 2014. Despite the larger damage taken by France from the current Covid crisis, the lagged effect of these reforms can still help reduce the competitiveness gap with Germany after a few years. However, a key driver of medium-term relative performance will also be how both economies adapt to major “disruption”-related sectoral challenges.
-
White papers
Fixed income dynamics in the current monetary and fiscal landscape
The global economy rebounded quickly during the summer from the coronavirus pandemic. In this phase of recovery, central banks played a key role in the massive supply of credit to governments and companies. To tackle the health crisis, almost all governments implemented large-scale fiscal stimulus and support measures, including corporate loan guarantees. At the same time, major central banks increased their purchases of sovereign debt to levels never seen before, played a backstop role in the corporate debt market and provided cheap liquidity to banks (in the case of the ECB).
-
White papers
Japan: Policy continuity expected under Suganomics
Striving to consolidate power with a snap election, Mr. Suga vows continuity of Abenomics and hints at additional fiscal stimulus. Domestic politics aside, we expect global factors and positioning to play a key role for Japanese equities and currency.
-
White papers
Contraction > recovery > late cycle: the cycle round trip is confirmed Advanced Investment Phazer: top-down assessment
The global recovery continues at different speeds and compositions at the regional level. Policies are pivotal in shaping the recovery trajectories, influencing market participants’ narratives and rebuilding confidence.
-
White papers
Markets scenarios & risks - October 2020
This month, we do not amend the narrative of our central and alternative scenario. Economic data confirm a slower recovery path in line with our central scenario and Central Banks maintain their accommodative stace. We maintain the probability of our central scenario at 70%, 20% for the downside scenario and 10% for the upside.
-
White papers
Macroeconomic picture - October 2020
Q3 economic rebound exceeds our expectations on GDP, prompting an upside revision to our August forecasts. Yet, the deceleration in late Q3 of several indicators is keeping us from extrapolating Q3 momentum into Q4. After some softening in 2020 H2, headline inflation will move along a gradual upward trend, stabilising around 2% from mid-2021 with possible temporary overshooting. As November 3 approaches, policymakers’ focus is shifting, with an increased risk that 2020 fiscal policy will become more diluted than expected, and with little visibility on the Phase 4 deal in particular.
-
White papers
Takeda Pharmaceutical - UK Institutional
Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers.